Elizabeth Garrett-Mayer - American Society of Clinical Oncology

基本信息

Career Trajectory

Bio

Elizabeth (Liz) Garrett-Mayer, PhD, is Vice President of the Center for Research and Analytics (CENTRA) at the American Society of Clinical Oncology (ASCO). Current CENTRA projects include initiatives to improve minority representation in cancer clinical trials, promoting dose optimization strategies in cancer drug development and in the post-approval setting, and the Targeted Agent and Profiling Utilization Registry (TAPUR) Study, a precision medicine clinical trial which has enrolled over 2000 patients with advanced cancer.

Research Interests

Papers共 527 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

SPIRIT-DEFINE Explanation and Elaboration: Recommendations for Enhancing Quality and Impact of Early Phase Dose-Finding Clinical Trials Protocols

Moreno Ursino, Guillermo Villacampa,Jan Rekowski,Munyaradzi Dimairo,Olga Solovyeva,Deborah Ashby,Jordan Berlin,Oliver Boix,Melanie Calvert,An-Wen Chan, Courtney H. Coschi,Thomas R. Jeffry Evans,Elizabeth Garrett-Mayer,Robert M. Golub,Christina Guo,Kathryn S. Hayward,Sally Hopewell,John D. Isaacs,S. Percy Ivy,Thomas Jaki,Olga Kholmanskikh,Andrew Kightley,Shing Lee, Rong Liu, Adrian Mander, Lynley Marshall,James Matcham,Dhrusti Patel, Richard Peck,Khadija Rerhou Rantell,Dawn P. Richards, Mahtab Rouhifard, Lesley Seymour, Yoshiya Tanaka,Christopher J. Weir,Johann de Bono,Christina Yap

ECLINICALMEDICINE (2025)

Cited0Views0WOSBibtex

State of Professional Well-Being, Satisfaction, and Career Plans among US Oncologists in 2023

Caroline Schenkel,Laura A Levit,Kelsey Kirkwood,Rebecca Spence,John M Burke,Colleen M Gallagher,Elizabeth Garrett-Mayer,Molly McGinnis, James D Morgante,Ray D Page,Judith Paice, Eric Tetzlaff,Eric Winer,Fay J Hlubocky,Tait Shanafelt

JCO oncology advancesno. 1 (2025): e2400010-e2400010

Cited0Views0WOSBibtex

CONSORT-DEFINE Explanation and Elaboration: Recommendations for Enhancing Reporting Quality and Impact of Early Phase Dose-Finding Clinical Trials

Jan Rekowski,Christina Guo,Olga Solovyeva,Munyaradzi Dimairo, Mahtab Rouhifard,Dhrusti Patel,Emily Alger,Deborah Ashby,Jordan Berlin,Oliver Boix,Melanie Calvert,An-Wen Chan, Courtney H. Coschi,Johann de Bono,Thomas R. Jeffry Evans,Elizabeth Garrett-Mayer,Robert M. Golub,Kathryn S. Hayward,Sally Hopewell,John D. Isaacs,S. Percy Ivy,Thomas Jaki,Olga Kholmanskikh,Andrew Kightley,Shing Lee, Rong Liu, Israel Maia, Adrian Mander, Lynley Marshall,James Matcham, Richard Peck,Khadija Rerhou Rantell,Dawn P. Richards, Lesley Seymour, Yoshiya Tanaka,Moreno Ursino,Christopher J. Weir,Christina Yap

ECLINICALMEDICINE (2025)

Cited0Views0WOSBibtex

A SITC Vision: Adapting Clinical Trials to Accelerate Drug Development in Cancer Immunotherapy

Thomas U Marron,Jason J Luke, Brianna Hoffner,Jane Perlmutter,Connie Szczepanek,Valsamo Anagnostou,Ann W Silk,Pedro J Romero,Elizabeth Garrett-Mayer,Leisha A Emens

Journal for immunotherapy of cancer（2025）

Cited0Views0WOSBibtex

Promoting Reasonable Career Expectations and Maximizing Professional Fulfillment for Academic Oncologists: ASCO Recommendations for Academic Medical Centers

Eric P Winer,Laura A Levit,Ethan Basch, Mariana Chavez-MacGregor, Ray Dubois, S Gail Eckhardt,Lee M Ellis,Clifford A Hudis,Deborah Schrag,Corey Speers,Breelyn A Wilky,Michal Tibbits,Rebecca Spence,Elizabeth Garrett-Mayer

Journal of clinical oncology official journal of the American Society of Clinical Oncologyno. 17 (2025): 2017-2023

Cited0Views0WOSBibtex

Nivolumab Plus Ipilimumab (N+I) in Patients (pts) with Pancreatic Cancer (PC) with BRCA1/2 Mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Peter Joel Hosein,Michael Rothe,Elizabeth Garrett-Mayer,Ari David Baron,Timothy Lewis Cannon,Evan P. Pisick,Evthokia Hobbs,Kathryn Finch Mileham, Matthew Joseph Tinguely,Marina Frimer,Philip Jordan Gold,Kelsey Klute,Sherise C. Rogers,Vaibhav Sahai,Davendra Sohal,Sachdev P. Thomas, Jerome Dallas Winegarden,Abby Gregory,Susan Halabi,Richard L. Schilsky

Journal of Clinical Oncologyno. 4_suppl (2025): 715-715

Cited0Views0Bibtex

More Frequent Than Annual Administration of COVID-19 Vaccination May Be Appropriate for Patients with Cancer

Mini Kamboj,M Kelsey Kirkwood,Kari Bohlke,Julie R Gralow,Elizabeth Garrett-Mayer,Charu Aggarwal

JCO oncology advancesno. 1 (2025): e2400107-e2400107

Cited0Views0WOSBibtex

Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer—CDK4/6 Inhibitors: ASCO Rapid Guideline Update Clinical Insights

Jennifer L Caswell-Jin,Rachel A Freedman,Michael J Hassett, Hao Tang,Elizabeth Garrett-Mayer,Mark R Somerfield,Sharon H Giordano

JCO oncology practice（2024）

Cited1Views0WOSBibtex

Current Issues in Dose-Finding Designs: A Response to the US Food and Drug Adminstrations’s Oncology Center of Excellence Project Optimus

Peter F. Thall,Elizabeth Garrett-Mayer,Nolan A. Wages,Susan Halabi,Ying Kuen Cheung

CLINICAL TRIALSno. 3 (2024): 267-272

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn